Ost-müük RxSight, Inc. - RXST CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Kauplemistingimused
| Hinnavahe | 0.13 | ||||||||
|
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.030779% | ||||||||
|
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | -0.013666% | ||||||||
| Ööpäeva tasu aeg | 22:00 (UTC) | ||||||||
| Min kauplemise kogus | 1 | ||||||||
| Valuuta | USD | ||||||||
| Tagatis | 20% | ||||||||
| Aktsiabörs | United States of America | ||||||||
| Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Võtmestatistika
| Eelmine sulgemine* | 13.92 |
| Avatud* | 13.55 |
| Aastane muutus* | 16.71% |
| Päeva ulatus* | 13.46 - 13.97 |
| 52 nädala ulatus | 9.78-16.99 |
| Keskmine maht (10 päeva) | 61.06K |
| Keskmine maht (3 kuud) | 1.42M |
| Turukapitalisatsioon | 387.83M |
| P/E suhtarv | -100.00K |
| Ringluses olevad aktsiad | 27.72M |
| Tulu | 41.34M |
| EPS | -2.43 |
| Dividendid (% kasumist) | N/A |
| Beeta | -100.00K |
| Järgmine tuluaruande kuupäev | N/A |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
|---|---|---|---|---|---|---|
| Feb 3, 2023 | 13.88 | 0.50 | 3.74% | 13.38 | 13.97 | 13.37 |
| Feb 2, 2023 | 13.92 | 0.25 | 1.83% | 13.67 | 14.18 | 13.53 |
| Feb 1, 2023 | 13.80 | 0.22 | 1.62% | 13.58 | 14.03 | 13.13 |
| Jan 31, 2023 | 13.93 | 0.45 | 3.34% | 13.48 | 14.19 | 13.47 |
| Jan 30, 2023 | 13.77 | 0.08 | 0.58% | 13.69 | 14.36 | 13.64 |
| Jan 27, 2023 | 14.18 | 1.27 | 9.84% | 12.91 | 14.42 | 12.90 |
| Jan 26, 2023 | 13.12 | 0.60 | 4.79% | 12.52 | 13.26 | 12.51 |
| Jan 25, 2023 | 12.82 | 0.10 | 0.79% | 12.72 | 12.94 | 12.13 |
| Jan 24, 2023 | 12.83 | 0.37 | 2.97% | 12.46 | 13.15 | 12.26 |
| Jan 23, 2023 | 12.86 | 0.16 | 1.26% | 12.70 | 13.16 | 12.45 |
| Jan 20, 2023 | 12.94 | 0.66 | 5.37% | 12.28 | 13.03 | 12.28 |
| Jan 19, 2023 | 12.76 | 0.77 | 6.42% | 11.99 | 12.78 | 11.81 |
| Jan 18, 2023 | 12.43 | -0.34 | -2.66% | 12.77 | 13.16 | 12.37 |
| Jan 17, 2023 | 12.96 | 0.19 | 1.49% | 12.77 | 13.16 | 12.77 |
| Jan 13, 2023 | 13.01 | 0.04 | 0.31% | 12.97 | 13.50 | 12.77 |
| Jan 12, 2023 | 13.22 | 0.33 | 2.56% | 12.89 | 13.57 | 12.83 |
| Jan 11, 2023 | 13.71 | 0.43 | 3.24% | 13.28 | 13.94 | 12.85 |
| Jan 10, 2023 | 13.31 | 0.13 | 0.99% | 13.18 | 13.98 | 12.97 |
| Jan 9, 2023 | 13.45 | 0.53 | 4.10% | 12.92 | 14.32 | 12.65 |
| Jan 6, 2023 | 12.88 | 0.37 | 2.96% | 12.51 | 13.03 | 12.47 |
RxSight, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Aastas
- Kvartalis
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Kogutulu | 2.241 | 14.678 | 22.593 |
| Tulu | 2.241 | 14.678 | 22.593 |
| Kulud, Kokku | 4.06 | 12.973 | 18.076 |
| Brutokasum | -1.819 | 1.705 | 4.517 |
| Kogu tegevuskulu | 48.311 | 50.09 | 75.38 |
| Müük/Üldine/admin kulud, kokku | 15.178 | 15.132 | 33.077 |
| Uuringud ja arendus | 29.42 | 21.819 | 24.202 |
| Depreciation / Amortization | 0.174 | 0.159 | 0.025 |
| Ootamatud kulutused (tulu) | -0.521 | 0.007 | 0 |
| Tulud majandustegevusest | -46.07 | -35.412 | -52.787 |
| Intressitulud (kulu), muud tulud, neto | 2.281 | 0.033 | -3.628 |
| Muud, neto | 170.033 | 63.011 | 7.735 |
| Netotulu enne makse | 126.244 | 27.632 | -48.68 |
| Netotulu pärast makse | 126.22 | 27.575 | -48.688 |
| Netotulu enne erikulusid | 126.22 | 27.575 | -48.688 |
| Netotulu | 126.22 | 27.575 | -48.688 |
| Total Adjustments to Net Income | -100.093 | -24.209 | 0 |
| Arvestatav tulu, v a erikulud | 26.127 | 3.366 | -48.688 |
| Arvestatav tulu, koos erikuludega | 26.127 | 3.366 | -48.688 |
| Jaotamisele kuuluv netotulu | 26.127 | 3.366 | -48.688 |
| Keskmine jaotamisele kuuluv aktsia kohta | 26.295 | 26.295 | 13.625 |
| Jaotatav EPS, v a erakorralised kulud | 0.99361 | 0.12801 | -3.57342 |
| Jaotamisele kuuluv normaal-EPS | 0.9738 | 0.12827 | -3.57342 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Kogutulu | 3.484 | 4.897 | 5.786 | 8.426 | 8.942 |
| Tulu | 3.484 | 4.897 | 5.786 | 8.426 | 8.942 |
| Kulud, Kokku | 2.365 | 5.709 | 4.445 | 5.557 | 5.181 |
| Brutokasum | 1.119 | -0.812 | 1.341 | 2.869 | 3.761 |
| Kogu tegevuskulu | 14.619 | 18.774 | 18.898 | 23.089 | 25.52 |
| Müük/Üldine/admin kulud, kokku | 5.603 | 6.495 | 9.135 | 11.686 | 13.689 |
| Uuringud ja arendus | 6.643 | 6.563 | 5.313 | 5.841 | 6.631 |
| Depreciation / Amortization | 0.008 | 0.007 | 0.005 | 0.005 | 0.019 |
| Tulud majandustegevusest | -11.135 | -13.877 | -13.112 | -14.663 | -16.578 |
| Intressitulud (kulu), muud tulud, neto | -0.681 | -0.811 | -1.068 | -1.069 | -1.014 |
| Muud, neto | 5.018 | 1.214 | 1.503 | 0 | 0 |
| Netotulu enne makse | -6.798 | -13.474 | -12.677 | -15.732 | -17.592 |
| Netotulu pärast makse | -6.805 | -13.477 | -12.673 | -15.734 | -17.596 |
| Netotulu enne erikulusid | -6.805 | -13.477 | -12.673 | -15.734 | -17.596 |
| Netotulu | -6.805 | -13.477 | -12.673 | -15.734 | -17.596 |
| Total Adjustments to Net Income | 0 | 0 | 0 | 0 | |
| Arvestatav tulu, v a erikulud | -6.805 | -13.477 | -12.673 | -15.734 | -17.596 |
| Arvestatav tulu, koos erikuludega | -6.805 | -13.477 | -12.673 | -15.734 | -17.596 |
| Jaotamisele kuuluv netotulu | -6.805 | -13.477 | -12.673 | -15.734 | -17.596 |
| Keskmine jaotamisele kuuluv aktsia kohta | 26.295 | 26.295 | 18.7325 | 27.5035 | 27.4256 |
| Jaotatav EPS, v a erakorralised kulud | -0.25879 | -0.51253 | -0.67653 | -0.57207 | -0.64159 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Jaotamisele kuuluv normaal-EPS | -0.25879 | -0.51253 | -0.67653 | -0.57207 | -0.64159 |
| Ootamatud kulutused (tulu) | 0 |
- Aastas
- Kvartalis
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Käibevarad kokku | 90.199 | 81.5 | 176.295 |
| Raha ja lühiajalised investeeringud | 80.668 | 68.975 | 159.332 |
| Raha ja ekvivalendid | 7.958 | 13.994 | 24.361 |
| Lühiajalised investeeringud | 72.71 | 54.981 | 134.971 |
| Laekumata arved, neto | 0.789 | 2.865 | 4.862 |
| Accounts Receivable - Trade, Net | 0.789 | 2.865 | 4.862 |
| Total Inventory | 7.219 | 8.288 | 8.032 |
| Prepaid Expenses | 1.523 | 1.372 | 4.069 |
| Total Assets | 110.432 | 100.677 | 192.721 |
| Property/Plant/Equipment, Total - Net | 19.25 | 18.606 | 15.501 |
| Property/Plant/Equipment, Total - Gross | 27.789 | 30.979 | 31.846 |
| Accumulated Depreciation, Total | -8.539 | -12.373 | -16.345 |
| Other Long Term Assets, Total | 0.983 | 0.571 | 0.925 |
| Total Current Liabilities | 8.457 | 11.6 | 11.077 |
| Accounts Payable | 2.199 | 1.134 | 1.689 |
| Accrued Expenses | 5.715 | 4.935 | 8.615 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.129 | 0.027 | 0.02 |
| Other Current Liabilities, Total | 0.414 | 5.504 | 0.753 |
| Total Liabilities | 87.462 | 44.906 | 54.479 |
| Total Long Term Debt | 0.054 | 24.436 | 39.777 |
| Long Term Debt | 0 | 24.399 | 39.76 |
| Capital Lease Obligations | 0.054 | 0.037 | 0.017 |
| Other Liabilities, Total | 78.951 | 8.87 | 3.625 |
| Total Equity | 22.97 | 55.771 | 138.242 |
| Redeemable Preferred Stock | 327.581 | 353.3 | 0 |
| Common Stock | 56.422 | 80.78 | 0.027 |
| Retained Earnings (Accumulated Deficit) | -360.224 | -377.503 | -479.276 |
| Other Equity, Total | -0.809 | -0.806 | -0.02 |
| Total Liabilities & Shareholders’ Equity | 110.432 | 100.677 | 192.721 |
| Total Common Shares Outstanding | 26.295 | 26.295 | 27.3668 |
| Additional Paid-In Capital | 617.511 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 77.844 | 75.546 | 186.336 | 176.295 | 161.147 |
| Raha ja lühiajalised investeeringud | 64.382 | 61.729 | 168.263 | 159.332 | 143.847 |
| Raha ja ekvivalendid | 24.385 | 41.731 | 68.278 | 24.361 | 24.132 |
| Lühiajalised investeeringud | 39.997 | 19.998 | 99.985 | 134.971 | 119.715 |
| Laekumata arved, neto | 2.266 | 3.936 | 4.357 | 4.862 | 5.626 |
| Accounts Receivable - Trade, Net | 2.266 | 3.936 | 4.357 | 4.862 | 5.626 |
| Total Inventory | 9.76 | 8.543 | 9.442 | 8.032 | 8.49 |
| Prepaid Expenses | 1.436 | 1.338 | 4.274 | 4.069 | 3.184 |
| Total Assets | 96.291 | 94.886 | 203.736 | 192.721 | 177.062 |
| Property/Plant/Equipment, Total - Net | 17.876 | 17.435 | 16.552 | 15.501 | 14.972 |
| Other Long Term Assets, Total | 0.571 | 1.905 | 0.848 | 0.925 | 0.943 |
| Total Current Liabilities | 6.857 | 11.102 | 9.176 | 11.077 | 10.659 |
| Accounts Payable | 1.861 | 2.342 | 1.691 | 1.689 | 2.587 |
| Accrued Expenses | 4.973 | 6.125 | 7.465 | 9.368 | 7.997 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.023 | 0.021 | 0.02 | 0.02 | 0.075 |
| Other Current Liabilities, Total | 0 | 2.614 | 0 | 0 | |
| Total Liabilities | 44.89 | 54.982 | 52.845 | 54.479 | 53.899 |
| Total Long Term Debt | 29.504 | 39.533 | 39.658 | 39.777 | 39.974 |
| Long Term Debt | 29.472 | 39.506 | 39.636 | 39.76 | 39.89 |
| Capital Lease Obligations | 0.032 | 0.027 | 0.022 | 0.017 | 0.084 |
| Other Liabilities, Total | 8.529 | 4.347 | 4.011 | 3.625 | 3.266 |
| Total Equity | 51.401 | 39.904 | 150.891 | 138.242 | 123.163 |
| Redeemable Preferred Stock | 353.3 | 353.3 | 0 | ||
| Common Stock | 0.042 | 0.004 | 0.027 | 0.027 | 0.027 |
| Additional Paid-In Capital | 136.269 | 137.838 | 614.418 | 617.511 | 620.106 |
| Retained Earnings (Accumulated Deficit) | -437.393 | -450.87 | -463.543 | -479.276 | -496.872 |
| Other Equity, Total | -0.817 | -0.368 | -0.011 | -0.02 | -0.098 |
| Total Liabilities & Shareholders’ Equity | 96.291 | 94.886 | 203.736 | 192.721 | 177.062 |
| Total Common Shares Outstanding | 26.295 | 26.295 | 27.3241 | 27.3668 | 27.4857 |
- Aastas
- Kvartalis
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Netotulu/algväärtus | 126.22 | 27.575 | -48.688 |
| Raha majandustegevusest | -40.619 | -35.203 | -44.708 |
| Raha majandustegevusest | 3.93 | 4.012 | 3.988 |
| Mittelikviidsed varad | -166.798 | -58.942 | 2.67 |
| Cash Taxes Paid | 0.019 | 0.061 | 0.02 |
| Makstud intressid | 0.026 | 0.425 | 3.187 |
| Muutused tööjõus | -3.971 | -7.848 | -2.678 |
| Tulu investeeringutelt | -5.87 | 15.591 | -81.907 |
| Kapitalikulutused | -4.086 | -2.539 | -1.94 |
| Muud rahavood investeeringutelt, kokku | -1.784 | 18.13 | -79.967 |
| Rahavood investeeringutelt | 1.33 | 25.237 | 137.342 |
| Rahavoogudesse investeerimine | 0 | -0.687 | -0.132 |
| Aktsiate emiteerimine (tagasiost), neto | 1.515 | 1.066 | 122.501 |
| Laenu väljastamine (kustutamine), neto | -0.185 | 24.858 | 14.973 |
| Muutused valuutakursside kõikumisest | 0.005 | -0.01 | |
| Rahaline kogumuutus | -45.154 | 5.625 | 10.717 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -6.805 | -20.282 | -32.954 | -48.688 | -17.596 |
| Cash From Operating Activities | -10.252 | -22.231 | -35.986 | -44.708 | -14.985 |
| Cash From Operating Activities | 0.966 | 1.959 | 2.969 | 3.988 | 1.035 |
| Non-Cash Items | -3.682 | -1.624 | -0.378 | 2.67 | 2.805 |
| Cash Taxes Paid | 0.011 | 0.014 | 0.019 | 0.02 | 0 |
| Cash Interest Paid | 0.584 | 1.294 | 2.241 | 3.187 | 0.928 |
| Changes in Working Capital | -0.731 | -2.284 | -5.623 | -2.678 | -1.229 |
| Cash From Investing Activities | 14.503 | 33.68 | -46.561 | -81.907 | 14.859 |
| Capital Expenditures | -0.498 | -1.321 | -1.575 | -1.94 | -0.37 |
| Other Investing Cash Flow Items, Total | 15.001 | 35.001 | -44.986 | -79.967 | 15.229 |
| Cash From Financing Activities | 6.144 | 16.391 | 136.938 | 137.342 | -0.098 |
| Financing Cash Flow Items | -0.04 | -0.364 | -0.366 | -0.132 | -0.362 |
| Issuance (Retirement) of Stock, Net | 1.193 | 1.771 | 122.325 | 122.501 | 0.308 |
| Issuance (Retirement) of Debt, Net | 4.991 | 14.984 | 14.979 | 14.973 | -0.044 |
| Foreign Exchange Effects | -0.004 | -0.003 | -0.007 | -0.01 | -0.005 |
| Net Change in Cash | 10.391 | 27.837 | 54.384 | 10.717 | -0.229 |
| Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
|---|---|---|---|---|---|---|
| RA Capital Management, LP | Hedge Fund | 11.0123 | 3052796 | 0 | 2022-09-30 | LOW |
| Longitude Capital Management Co., LLC | Venture Capital | 8.9772 | 2488613 | 0 | 2022-04-11 | LOW |
| H.I.G. Capital, LLC | Private Equity | 7.2508 | 2010037 | 0 | 2022-04-11 | |
| Wolfen (Richard M) | Individual Investor | 6.5918 | 1827349 | -89869 | 2021-12-31 | |
| RxSight I, L.L.C. | Corporation | 6.3804 | 1768757 | -248021 | 2022-04-11 | MED |
| OrbiMed Advisors, LLC | Investment Advisor/Hedge Fund | 4.339 | 1202833 | -180667 | 2022-09-30 | LOW |
| Kurtz (Ronald M) | Individual Investor | 3.3534 | 929610 | 3638 | 2022-04-11 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 3.1957 | 885894 | 35134 | 2022-09-30 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.8957 | 802749 | 130694 | 2022-09-30 | LOW |
| Millennium Management LLC | Hedge Fund | 1.752 | 485694 | -23774 | 2022-09-30 | HIGH |
| Corley (Andy J) | Individual Investor | 1.624 | 450210 | 92134 | 2022-04-11 | LOW |
| Schwartz (Daniel Mark) | Individual Investor | 1.5245 | 422628 | 3969 | 2021-08-03 | |
| Weinberg (Eric) | Individual Investor | 1.2658 | 350903 | 925 | 2022-04-11 | LOW |
| Cresset Asset Management, LLC | Investment Advisor/Hedge Fund | 1.1389 | 315719 | 0 | 2022-09-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.0497 | 291007 | 3765 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.0088 | 279648 | 51885 | 2022-09-30 | LOW |
| Point72 Asset Management, L.P. | Hedge Fund | 0.8572 | 237641 | 237641 | 2022-09-30 | HIGH |
| Bridger Management, LLC | Hedge Fund | 0.7999 | 221732 | -109700 | 2022-09-30 | |
| Parkman Healthcare Partners LLC | Hedge Fund | 0.6016 | 166761 | 51761 | 2022-09-30 | HIGH |
| Sessa Capital | Hedge Fund | 0.4898 | 135779 | -28503 | 2022-09-30 | MED |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group +485000+
Kauplejad
65000+
Igakuiste aktiivsete klientide arv
$48000000+
Igakuine investeerimise maht
$28000000+
Proovige nüüd Igakuiselt välja võetud
Kauplemiskalkulaator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Kauplemise vahendustasu
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Finantsvõimendus
20:1
- 20
- 100
- 500
- 1000
- 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind
Close
Lühike Pikk
RxSight, Inc. Company profile
Ettevõttest RxSight, Inc.
RxSight, Inc. on kommertsjärgus meditsiinitehnoloogia ettevõte. Ettevõte tegeleb patsientide nägemise parandamisega pärast kataraktioperatsiooni. Ettevõtte RxSight Light Adjustable Lens system (RxSight system), mis koosneb RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) ja lisaseadmetest, on silmasisese läätse (IOL) tehnoloogia, mis võimaldab arstidel kohandada ja optimeerida patsientide nägemisteravust pärast katarakti operatsiooni. Selle LAL on valmistatud valgustundlikust materjalist, mis muudab kuju vastuseks selle LDD poolt genereeritud ultraviolettvalguse (UV) mustritele. Selle RxSight-süsteem aitab kirurgil teostada LAL-i implanteerimiseks standardset kataraktiprotseduuri ja seejärel kasutada LDD-d, et muuta läätset patsiendi nägemistulemuste jaoks vajaliku nägemiskorrektsiooniga. Alternatiivsed IOL-tehnoloogiad ei ole pärast operatsiooni reguleeritavad ja seetõttu peavad patsiendid tegema operatsioonieelsed valikud oma nägemise eelistuste kohta.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
100 Columbia Street
Suite 120
ALISO VIEJO
CALIFORNIA 92656
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 485,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com